• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1120225-12
Device Problems Break (1069); Difficult to Remove (1528); Material Separation (1562); Failure to Advance (2524); Deformation Due to Compressive Stress (2889); Difficult to Advance (2920); Device Dislodged or Dislocated (2923); Material Deformation (2976)
Patient Problems Foreign Body In Patient (2687); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/20/2022
Event Type  malfunction  
Manufacturer Narrative
The device is expected to be returned for investigation.It has not yet been received.A follow-up report will be submitted with all additional relevant information.N/a.
 
Event Description
It was reported that the procedure was to treat a moderately tortuous, heavily calcified descending artery bifurcating with the diagonal artery.When advancing a 2.25x12mm xience alpine, resistance was met with the anatomy and guide wire and the device failed to cross.During removal of the xience alpine it met resistance with the guide wire.The stent implant was noted as flared and hypotube was noted to be heavily fractured and kinked, but remained in one piece.The device was simply removed altogether with the guide wire.A 2x12mm xience alpine was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
 
Event Description
It was reported that the procedure was to treat a moderately tortuous, heavily calcified descending artery bifurcating with the diagonal artery.When advancing a 2.25x12mm xience alpine, resistance was met with the anatomy and guide wire and the device failed to cross.During removal of the xience alpine it met resistance with the guide wire.The stent implant was noted as flared and hypotube was noted to be heavily fractured and kinked, but remained in one piece.The device was simply removed altogether with the guide wire.A 2x12mm xience alpine was used to successfully complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.Device analysis noted that [the separated inner member in between the two inner member separations was not returned] it is unknown if the separated material remains in the anatomy.Subsequent to the initially filed mdr report, the account confirmed that the stent implant dislodged while the device was being advanced due to resistance with anatomy.The dislodged stent was removed from the anatomy over the guide wire, with the guide catheter.No additional information was provided.
 
Manufacturer Narrative
Type of reportable event changed from malfunction to serious injury health effect clinical code 2199, 4582 were removed.
 
Manufacturer Narrative
A visual inspection was performed on the returned device.The reported break could not be confirmed.The reported failure to advance could not be tested as it was based on the operational context of the procedure.The reported difficult to advance and difficult to remove could not be tested due to the device condition.The reported material deformation, stent dislodgement, and deformation due to compressive stress were confirmed.A review of the lot history record revealed no manufacturing nonconformities that would have contributed to this complaint.Additionally, a review of the complaint history of the reported lot did not indicate a lot specific quality issue.The investigation determined the reported difficult to advance, failure to advance, material deformation, difficult to remove, deformation due to compressive stress, stent dislodgement and the subsequent treatment appear to be related to the operational context of the procedure.A conclusive cause for the reported shaft break could not be determined as it was not confirmed.Additionally, a conclusive cause for the reported patient effect, and its relationship to the product, if any, cannot be determined.In this case, it is likely that the sds interacted with the moderately tortuous, heavily calcified anatomy during advancement, as resistance was noted, causing the reported failure to advance, material deformation (damaged stent), stent dislodgement and noted bunched inner member.Further interaction with the guide wire in addition to the challenging anatomy during advancement/retraction likely contributed to the noted smashed/twisted tip, causing the reported difficult to advance/position and difficult to remove (guide wire resistance).Manipulation of the device during retraction, as resistance was again noted, likely contributed to the reported deformation due to compressive stress (shaft/bent hypotube) in addition to the noted stretched inner/outer member, ultimately causing the noted inner member and balloon separation.Although the reported shaft break was not confirmed, it is possible that the noted inner member and balloon separation was reported as the break; however, this cannot be determined.There is no indication of a product quality issue with respect to manufacture, design, or labeling of the device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE ALPINE EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key13536351
MDR Text Key289468896
Report Number2024168-2022-01557
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeBR
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 05/04/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/09/2022
Device Catalogue Number1120225-12
Device Lot Number9060341
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/28/2022
Initial Date FDA Received02/15/2022
Supplement Dates Manufacturer Received03/31/2022
05/03/2022
Supplement Dates FDA Received04/20/2022
05/05/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/10/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age72 YR
Patient SexFemale
Patient Weight62 KG
-
-